DK732988A - Fremgangsmaade til genteknologisk fremstilling af antistoffer - Google Patents

Fremgangsmaade til genteknologisk fremstilling af antistoffer

Info

Publication number
DK732988A
DK732988A DK732988A DK732988A DK732988A DK 732988 A DK732988 A DK 732988A DK 732988 A DK732988 A DK 732988A DK 732988 A DK732988 A DK 732988A DK 732988 A DK732988 A DK 732988A
Authority
DK
Denmark
Prior art keywords
genetechnological
antibodies
procedure
production
hapten
Prior art date
Application number
DK732988A
Other languages
Danish (da)
English (en)
Other versions
DK732988D0 (da
Inventor
Andreas Plueckthun
Arne Skerra
Original Assignee
Andreas Plueckthun
Arne Skerra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6343878&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK732988(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Andreas Plueckthun, Arne Skerra filed Critical Andreas Plueckthun
Publication of DK732988D0 publication Critical patent/DK732988D0/da
Publication of DK732988A publication Critical patent/DK732988A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DK732988A 1987-12-31 1988-12-30 Fremgangsmaade til genteknologisk fremstilling af antistoffer DK732988A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873744595 DE3744595A1 (de) 1987-12-31 1987-12-31 Verfahren zur gentechnischen herstellung von antikoerpern

Publications (2)

Publication Number Publication Date
DK732988D0 DK732988D0 (da) 1988-12-30
DK732988A true DK732988A (da) 1989-07-01

Family

ID=6343878

Family Applications (1)

Application Number Title Priority Date Filing Date
DK732988A DK732988A (da) 1987-12-31 1988-12-30 Fremgangsmaade til genteknologisk fremstilling af antistoffer

Country Status (12)

Country Link
EP (1) EP0324162B1 (fr)
JP (1) JP2771204B2 (fr)
KR (1) KR970007861B1 (fr)
AT (1) ATE102651T1 (fr)
AU (1) AU628310B2 (fr)
DE (2) DE3744595A1 (fr)
DK (1) DK732988A (fr)
ES (1) ES2063022T3 (fr)
HU (1) HU212592B (fr)
IE (1) IE62257B1 (fr)
PT (1) PT89362B (fr)
ZA (1) ZA889711B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5576195A (en) * 1985-11-01 1996-11-19 Xoma Corporation Vectors with pectate lyase signal sequence
US5618920A (en) * 1985-11-01 1997-04-08 Xoma Corporation Modular assembly of antibody genes, antibodies prepared thereby and use
US7063943B1 (en) 1990-07-10 2006-06-20 Cambridge Antibody Technology Methods for producing members of specific binding pairs
GB9206318D0 (en) * 1992-03-24 1992-05-06 Cambridge Antibody Tech Binding substances
US6172197B1 (en) 1991-07-10 2001-01-09 Medical Research Council Methods for producing members of specific binding pairs
US6916605B1 (en) 1990-07-10 2005-07-12 Medical Research Council Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
SE9101433D0 (sv) * 1991-05-13 1991-05-13 Marianne Hansson Recombinant dna sequence and its use
US6492160B1 (en) 1991-05-15 2002-12-10 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US5858657A (en) * 1992-05-15 1999-01-12 Medical Research Council Methods for producing members of specific binding pairs
US6225447B1 (en) 1991-05-15 2001-05-01 Cambridge Antibody Technology Ltd. Methods for producing members of specific binding pairs
US5871907A (en) 1991-05-15 1999-02-16 Medical Research Council Methods for producing members of specific binding pairs
US5962255A (en) * 1992-03-24 1999-10-05 Cambridge Antibody Technology Limited Methods for producing recombinant vectors
JP3951062B2 (ja) 1991-09-19 2007-08-01 ジェネンテック・インコーポレーテッド 少なくとも遊離のチオールとして存在するシステインを有する抗体フラグメントの大腸菌での発現、２官能性Ｆ（ａｂ’）２抗体の産生のための使用
US5837491A (en) * 1991-11-04 1998-11-17 Xoma Corporation Polynucleotides encoding gelonin sequences
US6146850A (en) * 1991-11-04 2000-11-14 Xoma Corporation Proteins encoding gelonin sequences
US5621083A (en) * 1991-11-04 1997-04-15 Xoma Corporation Immunotoxins comprising ribosome-inactivating proteins
WO1993011236A1 (fr) 1991-12-02 1993-06-10 Medical Research Council Production d'anticorps anti-auto-antigenes a partir de repertoires de segments d'anticorps affiches sur phage
WO1993012246A1 (fr) * 1991-12-18 1993-06-24 The University Of Calgary Vecteurs d'expression-secretion servant a produire des fragments fv biologiquement actifs
US5733743A (en) * 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
US7368111B2 (en) 1995-10-06 2008-05-06 Cambridge Antibody Technology Limited Human antibodies specific for TGFβ2
GB9705376D0 (en) * 1997-03-14 1997-04-30 Harris William J Antibody fragment formulations and assay formats for detecting the presence an d concentration of analytes
US6492497B1 (en) 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
EP1908769A1 (fr) * 2001-08-27 2008-04-09 Genentech, Inc. Système d'expression d'anticorps et ensemble
US20030077739A1 (en) * 2001-08-27 2003-04-24 Genentech, Inc. System for antibody expression and assembly
PL2102354T3 (pl) * 2007-01-12 2018-01-31 Dow Global Technologies Llc Urządzenie i sposoby osmotycznego szokowania komórek
WO2015087271A2 (fr) 2013-12-12 2015-06-18 Koninklijke Philips N.V. Procédé permettant à des adaptateurs d'alimentation en courant alternatif (ca)/courant continu (cc) standard de fonctionner dans des conditions à champs magnétiques intenses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
EP0196864A3 (fr) * 1985-03-25 1988-03-23 Cetus Corporation Scission et sécrétion des protéines recombinantes à l'aide du système de la phosphatase alcaline, séquences de l'ADN à utiliser dans ce système et cellules transformées au moyen de ces séquences
EP0234592A1 (fr) * 1986-02-28 1987-09-02 Teijin Limited Plasmide contenant un fragment d'ADN codant pour la région Fc de protéine immunoglobuline G humaine, et son utilisation pour la production de ladite protéine
JPS62201581A (ja) * 1986-02-28 1987-09-05 Rikagaku Kenkyusho 新規プラスミド、微生物細胞及びヒト免疫グロブリンＧ　Ｆｃ領域蛋白質の製造方法
AU2263288A (en) * 1987-07-16 1989-02-13 Codon Transfected cells containing plasmids having genes oriented in opposing directions and methods of obtaining the same
CA1341235C (fr) * 1987-07-24 2001-05-22 Randy R. Robinson Assemblage modulaire de genes d'anticorps, anticorps prepares de cette facon, ainsi que leur usage

Also Published As

Publication number Publication date
EP0324162B1 (fr) 1994-03-09
JPH02799A (ja) 1990-01-05
JP2771204B2 (ja) 1998-07-02
HU212592B (en) 1996-08-29
DE3888337D1 (de) 1994-04-14
AU628310B2 (en) 1992-09-17
IE883893L (en) 1989-06-30
HUT49169A (en) 1989-08-28
EP0324162A1 (fr) 1989-07-19
PT89362A (pt) 1989-12-29
IE62257B1 (en) 1995-01-11
KR970007861B1 (ko) 1997-05-17
PT89362B (pt) 1993-08-31
DE3744595A1 (de) 1989-07-13
DK732988D0 (da) 1988-12-30
ATE102651T1 (de) 1994-03-15
AU2761788A (en) 1989-07-06
ES2063022T3 (es) 1995-01-01
KR890010203A (ko) 1989-08-07
ZA889711B (en) 1989-09-27

Similar Documents

Publication Publication Date Title
DK732988A (da) Fremgangsmaade til genteknologisk fremstilling af antistoffer
NO913186D0 (no) Fremgangsmaate for anvendelse og syntese av peptider.
FI883541A0 (fi) Dna-strukturer innehaollande styrsekvensen av kluyveromyces- -faktorn.
DK0920505T3 (da) Pattedyrcelleoverfladeantigener og tilhörende reagenser
WO1998027114A3 (fr) Antigenes de surface mammaliens et reactifs associes
LU91756I2 (fr) Denosumab
DK305688D0 (da) Antistof og immunoassay
WO1998011226A3 (fr) Chemokines de mammiferes et reactifs apparentes
ATE265533T1 (de) Saeugetierchemokine
ATE294237T1 (de) S?ugetier thymokingene
EP0276984A3 (fr) Dosage des anticorps anti-ADNs
SE8802939D0 (sv) A method for the production and isolation of a fusion protein in eukaryotic cells
AR002004A1 (es) Proteina slam, anticuerpo o un fragmento del mismo que se fija a dicha proteina, metodo de purificacion, acido nucleico que codifica dicha proteina,vector de expresion, equipo que la contiene, metodo de deteccion, metodo de modulacion y metodo para preparar una composicion farmaceutica.
Hoag et al. Optimal conditions for isolating human placental alkaline phosphatase by immunosorption
WO2002063009A3 (fr) Proteines de mammiferes lp et reactifs associes
WO2002028903A2 (fr) Banques de chaines lourdes

Legal Events

Date Code Title Description
ATS Application withdrawn